
Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Fierce editors discuss a fascinating Valeant Pharmaceuticals conference call, Pfizer's desire for a big buyout and the creaky world of biotech IPOs.
Valeant's semantic innovation, Pfizer's future and the slow trickle of biotech IPOs is an episode from FierceBiotech Radio. Fierce editors discuss a fascinating Valeant Pharmaceuticals conference call, Pfizer's desire for a big buyout and t...
This episode belongs to FierceBiotech Radio.
Use the player on this page to stream the episode online.
Published Oct 29, 2015, 25:08 long, audio available.
Fierce editors discuss a fascinating Valeant Pharmaceuticals conference call, Pfizer's desire for a big buyout and the creaky world of biotech IPOs.
You can listen to Valeant's semantic innovation, Pfizer's future and the slow trickle of biotech IPOs online on Radio and Podcast. Open the player on this page to stream the available audio.
Valeant's semantic innovation, Pfizer's future and the slow trickle of biotech IPOs is an episode from FierceBiotech Radio.
This episode is 25:08 long.
This episode was published on Oct 29, 2015.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from FierceBiotech Radio when more episodes are available from the podcast feed.
You can listen to Valeant's semantic innovation, Pfizer's future and the slow trickle of biotech IPOs on this page when the episode audio is available from the podcast feed.
Valeant's semantic innovation, Pfizer's future and the slow trickle of biotech IPOs is from FierceBiotech Radio.
Published Oct 29, 2015 and 25:08 long